Use of deferiprone and methods to treat and / or prevent Friedreich's ataxia resulting from intracellular iron mismatch

• 收藏
• 分享

专利权人:

APOTEX TECHNOLOGIES INC.

发明人:

MUNNICH, ARNOLD,SPINO, MICHAEL,CABANTCHIK, IOAV

申请号：

DK07701800

公开号：

DK1991225T3

申请日:

2007.02.21

申请国别(地区):

DK

年份:

2013

代理人:

摘要：

A therapeutically effective amount of deferiprone or deferasirox or physiologically acceptable salts thereof for the prevention, stabilization, treatment, or reversal of iron-induced FRDA disease in patients resulting from mitochondrial iron-induced damage to preferentially reduce the iron stores in the mitochondria. Also for the treatment of other conditions affecting the brain where a key element in the generation of the resultant pathology is the intracellular mishandling of iron.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/